Enliven Therapeutics Inc (NAS:ELVN)
$ 22.57 0.03 (0.13%) Market Cap: 1.06 Bil Enterprise Value: 741.37 Mil PE Ratio: 0 PB Ratio: 3.32 GF Score: 22/100

Enliven Therapeutics Inc and Imara Inc Announce Merger Agreement-M&A Call Transcript

Oct 13, 2022 / 09:00PM GMT
Operator

Good afternoon. My name is Abby, and (technical difficulty) conference operator today. At this time, I would like to welcome everyone to the Imara and Enliven conference call. All lines have been placed on mute to prevent any background noise. Michael Gray, Chief Financial Officer and Chief Operating Officer of Imara, you may begin your conference.

Michael Gray
Imara Inc. - CFO & COO

Okay. Thank you and good afternoon, everyone. Joining me on today's call are Rahul Ballal, Imara's President and Chief Executive Officer; and Sam Kintz, Co-Founder, President, and Chief Executive Officer of Enliven. As you likely saw, Enliven and Imara issued a joint press release today announcing the signing of a definitive merger agreement.

Before I turn the call over to Rahul and Sam, I would like to remind everyone that this discussion and the accompanying presentation will contain forward-looking statements based upon the current expectations of Imara and Enliven Therapeutics, which include, but are not limited to statements regarding the expected timing,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot